Here is a comma-separated list of relevant tags for the post title: “MVMT

Re-engineering an HIV patient’s own immune cells to find and destroy the virus succeeded in controlling the infection in a small first-in-human study, but researchers said work is needed to confirm the findings and determine which patients are most likely to benefit. The Phase 1 trial involved CAR-T, a one-time therapy in which a patient’s…